济南前列腺肥大怎么治济南前列腺炎要挂什么科,济南龟头敏感度降低怎么治疗,济南阴囊湿疹怎么治疗,济南龟头敏感导致早射怎么办,济南重度早泄的治疗,济南龟头敏感太强怎么办,济南治疗严重阳痿的药

President-elect Joe Biden is heading to Georgia to campaign for the Democratic candidates in the state's two critical U.S. Senate runoffs.Biden says he'll travel to Atlanta on Tuesday to support Jon Ossoff, the Rev. Raphael Warnock and the Democratic ticket in the Jan. 5 runoffs, which will determine which party controls the Senate at the outset of his presidency.Ossoff faces Republican Sen. David Perdue. Warnock faces GOP Sen. Kelly Loeffler.Republicans need one seat for a Senate majority. Democrats need both to make Vice President-elect Kamala Harris the tie-breaking vote.President Donald Trump used a weekend rally in Valdosta, Georgia, to push supporters to turn out for Perdue and Loeffler.Georgia has long been a Republican stronghold but may be on the road to swing state status, particularly after Biden became the first Democratic presidential candidate since Bill Clinton in 1992 to carry the state. 924

President Donald Trump’s physical Dr. Sean Conley confirmed Friday that the president is taking an experimental antibody treatment to help him fight the coronavirus following his diagnosis this morning.Dr. Conley said Friday afternoon that Trump is "fatigued."Trump is taking the Regeneron antibody cocktail, which is currently in a clinical trial. Conley said that Trump has been treated with a single 8 gram dose, which Conley said was infused "without incident."Trump is also said to be taking Vitamin D, zinc, famotidine, melatonin and daily aspirin. The Regeneron trial has only been tried on 275 patients as of this week, but the company said earlier this week that it has showed promising results.Regeneron confirmed that Trump was given the treatment under a "compassionate use request.""In the USA, this type of compassionate use program is also known as an Expanded Access Program (EAP) and is intended for patients with serious or life-threatening conditions, who do not have any viable or available treatment options, and are unable to participate in ongoing clinical trials," Regeneron said in a statement. The plan is to enroll 2,000 patients in early studies of the treatment."After months of incredibly hard work by our talented team, we are extremely gratified to see that Regeneron's antibody cocktail REGN-COV2 rapidly reduced viral load and associated symptoms in infected COVID-19 patients," said George D. Yancopoulos, M.D., Ph.D., President and Chief Scientific Officer of Regeneron. "The greatest treatment benefit was in patients who had not mounted their own effective immune response, suggesting that REGN-COV2 could provide a therapeutic substitute for the naturally-occurring immune response. These patients were less likely to clear the virus on their own, and were at greater risk for prolonged symptoms.The treatment is a combination of two monoclonal and was designed specifically to block infectivity of SARS-CoV-2, the virus that causes COVID-19, the company said.“The two potent, virus-neutralizing antibodies that form REGN-COV2 bind non-competitively to the critical receptor binding domain of the virus's spike protein, which diminishes the ability of mutant viruses to escape treatment and protects against spike variants that have arisen in the human population, as detailed in Science.” Regeneron said in a statement. “Preclinical studies have shown that REGN-COV2 reduced the amount of virus and associated damage in the lungs of non-human primates.”According to Regeneron, the treatment has been tried on hospitalized and non-hospitalized patients and as a preventative for those who have had close contact with coronavirus patients. So far, the drug has been particularly promising for non-hospitalized patients.Regeneron said the treatment reduces the viral load from the coronavirus, and boosts the body’s immune response to the virus. 2890

Republicans suffered setbacks to court challenges over the presidential election in three battleground states on Friday as a national law firm that came under fire for its work for President Trump’s campaign withdrew from a major Pennsylvania case. The legal blows began when a federal appeals court rejected an effort to block about 9,300 mail ballots that arrived after Election Day in Pennsylvania. The judges noted the “unprecedented challenges” facing the nation during the COVID-19 pandemic. Meanwhile, a Michigan judge found no evidence of fraud in refusing to stop the certification of Detroit-area election results. And in Arizona, a judge dismissed a Trump campaign’s lawsuit seeking the inspection of ballots in metro Phoenix.President-elect Joe Biden is projected win at least 290 Electoral College votes, and could add to his lead depending on a hand recount in Georgia. Biden is leading Georgia by more than 12,000 votes. 944

Rescuers in Mexico City pushed through debris Thursday at an elementary school in an urgent attempt to reach a 12-year-girl, two days after a powerful earthquake trapped her and killed at least 250 people across central Mexico.The rescue attempt at the capital's Colegio Enrique Rebsamen came amid concerns the structure could buckle further. It was one of many searches underway at buildings that collapsed in the region after Tuesday's magnitude 7.1 quake, the country's second major temblor in less than two weeks. 525

Queen Elizabeth II is reportedly down to just one dog after the passing of her dorgi, Vulcan, NBC News and People reported.According to NBC's TODAY, the dorgi is a crossbreed corgi and a dachshund. The queen reportedly came up with past breeding of "generations of her corgis with dachshunds belonging to her late sister, Princess Margaret."People reported that Vulcan died at Windsor Castle, where the queen, 94, and husband Prince Philip have been since March amid the coronavirus pandemic.The leaves the queen with just one dog, another dorgi named Candy, People reported.Vulcan's passing comes just two weeks after Prince William and Kate Middleton, the Duchess of Cambridge's family dog Lupo died, according to NBC News. 733